Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.
Identifieur interne : 000515 ( Main/Exploration ); précédent : 000514; suivant : 000516Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.
Auteurs : Brenda L. Coleman [Canada] ; Andrea K. Boggild ; Steven J. Drews ; Yan Li ; Donald E. Low ; Allison J. McgeerSource :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Antiviraux (administration et posologie), Canada (épidémiologie), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (traitement médicamenteux), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Oséltamivir (administration et posologie), Personnel de santé (statistiques et données numériques), Projets pilotes (MeSH), Saisons (MeSH), Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Antiviraux, Oséltamivir, Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Personnel de santé.
- traitement médicamenteux : Grippe humaine.
- épidémiologie : Canada, Grippe humaine.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Jeune adulte, Mâle, Projets pilotes, Saisons.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Adult (MeSH), Antiviral Agents (administration & dosage), Canada (epidemiology), Female (MeSH), Health Personnel (statistics & numerical data), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Oseltamivir (administration & dosage), Pilot Projects (MeSH), Seasons (MeSH), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Antiviral Agents, Influenza Vaccines, Oseltamivir.
- geographic , epidemiology : Canada.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Health Personnel.
- Adult, Female, Humans, Male, Middle Aged, Pilot Projects, Seasons, Young Adult.
Abstract
BACKGROUND
Data regarding both rates of acute respiratory illness in health care workers and experience with long-term antiviral prophylaxis are sparse.
OBJECTIVE
To determine the efficacy and tolerability of oseltamivir prophylaxis versus seasonal influenza vaccine for the prevention of influenza among health care workers.
METHODS
We conducted a pilot, randomized control study during the 2007/2008 influenza season in a tertiary care setting. Adult health care workers 18-69 years of age were recruited and randomly assigned in a 4:1 ratio to receive either oseltamivir (Tamiflu(®); Roche) 75 mg once daily prophylaxis or seasonal influenza (Fluviral(®)) vaccine.
RESULTS
Of 56 adults enrolled, 12 received vaccine and 44 received prophylaxis. Incidence of symptomatic laboratory-confirmed influenza was similar for participants in the vaccine and prophylaxis arms (17% and 24%, respectively; P = 0·71). Participants who developed an acute respiratory illness during the study period reported working 85% of scheduled work days, and 29% stated that they worked despite feeling miserable because they were too busy to stay home. Of 42 participants who initiated oseltamivir prophylaxis, four discontinued it owing to side effects. Median duration of oseltamivir prophylaxis was 121 days, with 34 (81%) continuing ≥12 weeks.
CONCLUSIONS
During an extended season of suboptimal vaccine match, 22% of health care workers receiving antiviral prophylaxis or seasonal influenza vaccine developed symptomatic laboratory-confirmed influenza. Long-term antiviral prophylaxis against influenza was generally well tolerated with good compliance.
DOI: 10.1111/j.1750-2659.2011.00245.x
PubMed: 21668681
PubMed Central: PMC5780657
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.</title><author><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name><affiliation wicri:level="1"><nlm:affiliation>Mount Sinai Hospital, Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Mount Sinai Hospital, Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Boggild, Andrea K" sort="Boggild, Andrea K" uniqKey="Boggild A" first="Andrea K" last="Boggild">Andrea K. Boggild</name></author><author><name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name></author><author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name></author><author><name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name></author><author><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21668681</idno><idno type="pmid">21668681</idno><idno type="doi">10.1111/j.1750-2659.2011.00245.x</idno><idno type="pmc">PMC5780657</idno><idno type="wicri:Area/Main/Corpus">000529</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000529</idno><idno type="wicri:Area/Main/Curation">000529</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000529</idno><idno type="wicri:Area/Main/Exploration">000529</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.</title><author><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name><affiliation wicri:level="1"><nlm:affiliation>Mount Sinai Hospital, Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Mount Sinai Hospital, Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Boggild, Andrea K" sort="Boggild, Andrea K" uniqKey="Boggild A" first="Andrea K" last="Boggild">Andrea K. Boggild</name></author><author><name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name></author><author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name></author><author><name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name></author><author><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Antiviral Agents (administration & dosage)</term><term>Canada (epidemiology)</term><term>Female (MeSH)</term><term>Health Personnel (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Oseltamivir (administration & dosage)</term><term>Pilot Projects (MeSH)</term><term>Seasons (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antiviraux (administration et posologie)</term><term>Canada (épidémiologie)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Oséltamivir (administration et posologie)</term><term>Personnel de santé (statistiques et données numériques)</term><term>Projets pilotes (MeSH)</term><term>Saisons (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term><term>Influenza Vaccines</term><term>Oseltamivir</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Health Personnel</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Personnel de santé</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Seasons</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Projets pilotes</term><term>Saisons</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Data regarding both rates of acute respiratory illness in health care workers and experience with long-term antiviral prophylaxis are sparse.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>To determine the efficacy and tolerability of oseltamivir prophylaxis versus seasonal influenza vaccine for the prevention of influenza among health care workers.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We conducted a pilot, randomized control study during the 2007/2008 influenza season in a tertiary care setting. Adult health care workers 18-69 years of age were recruited and randomly assigned in a 4:1 ratio to receive either oseltamivir (Tamiflu(®); Roche) 75 mg once daily prophylaxis or seasonal influenza (Fluviral(®)) vaccine.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Of 56 adults enrolled, 12 received vaccine and 44 received prophylaxis. Incidence of symptomatic laboratory-confirmed influenza was similar for participants in the vaccine and prophylaxis arms (17% and 24%, respectively; P = 0·71). Participants who developed an acute respiratory illness during the study period reported working 85% of scheduled work days, and 29% stated that they worked despite feeling miserable because they were too busy to stay home. Of 42 participants who initiated oseltamivir prophylaxis, four discontinued it owing to side effects. Median duration of oseltamivir prophylaxis was 121 days, with 34 (81%) continuing ≥12 weeks.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>During an extended season of suboptimal vaccine match, 22% of health care workers receiving antiviral prophylaxis or seasonal influenza vaccine developed symptomatic laboratory-confirmed influenza. Long-term antiviral prophylaxis against influenza was generally well tolerated with good compliance.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21668681</PMID><DateCompleted><Year>2012</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.</ArticleTitle><Pagination><MedlinePgn>404-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1750-2659.2011.00245.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Data regarding both rates of acute respiratory illness in health care workers and experience with long-term antiviral prophylaxis are sparse.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the efficacy and tolerability of oseltamivir prophylaxis versus seasonal influenza vaccine for the prevention of influenza among health care workers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a pilot, randomized control study during the 2007/2008 influenza season in a tertiary care setting. Adult health care workers 18-69 years of age were recruited and randomly assigned in a 4:1 ratio to receive either oseltamivir (Tamiflu(®); Roche) 75 mg once daily prophylaxis or seasonal influenza (Fluviral(®)) vaccine.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 56 adults enrolled, 12 received vaccine and 44 received prophylaxis. Incidence of symptomatic laboratory-confirmed influenza was similar for participants in the vaccine and prophylaxis arms (17% and 24%, respectively; P = 0·71). Participants who developed an acute respiratory illness during the study period reported working 85% of scheduled work days, and 29% stated that they worked despite feeling miserable because they were too busy to stay home. Of 42 participants who initiated oseltamivir prophylaxis, four discontinued it owing to side effects. Median duration of oseltamivir prophylaxis was 121 days, with 34 (81%) continuing ≥12 weeks.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">During an extended season of suboptimal vaccine match, 22% of health care workers receiving antiviral prophylaxis or seasonal influenza vaccine developed symptomatic laboratory-confirmed influenza. Long-term antiviral prophylaxis against influenza was generally well tolerated with good compliance.</AbstractText><CopyrightInformation>© 2011 Blackwell Publishing Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Brenda L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boggild</LastName><ForeName>Andrea K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Drews</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Donald E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>Allison J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>20O93L6F9H</RegistryNumber><NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21668681</ArticleId><ArticleId IdType="doi">10.1111/j.1750-2659.2011.00245.x</ArticleId><ArticleId IdType="pmc">PMC5780657</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Can Commun Dis Rep. 2008 Jul;34(ACS-3):1-46</Citation><ArticleIdList><ArticleId IdType="pubmed">18802991</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2008 Jul 27;86(2):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18645488</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Epidemiol. 1994 Aug;10(4):487-90</Citation><ArticleIdList><ArticleId IdType="pubmed">7843364</ArticleId></ArticleIdList></Reference><Reference><Citation>J Epidemiol Community Health. 2000 Jul;54(7):502-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10846192</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2009 Mar;13(2):261-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18922718</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2006 Jul 10;4:17</Citation><ArticleIdList><ArticleId IdType="pubmed">16831228</ArticleId></ArticleIdList></Reference><Reference><Citation>J Spinal Cord Med. 2007;30(1):20-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17387806</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2008 Mar 25;26(14):1786-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18336965</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Dec 08;339:b5106</Citation><ArticleIdList><ArticleId IdType="pubmed">19995812</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Targets. 2009 Oct;10(10):1041-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19860646</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Oct 28;341(18):1336-43</Citation><ArticleIdList><ArticleId IdType="pubmed">10536125</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1993 Dec;83(12):1712-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8259800</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 2008 Jul;34(7):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18802987</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Aug 10;339:b3172</Citation><ArticleIdList><ArticleId IdType="pubmed">19666987</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Aug 1;198(3):312-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18522501</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19644442</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Rep. 2007 Nov;18(4):9-19</Citation><ArticleIdList><ArticleId IdType="pubmed">18074993</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):835-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20428910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Lab Sci. 2008 Autumn;38(4):376-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18988931</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nurs Adm. 2005 Jan;35(1):23-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15647665</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 1989 Aug;17(4):202-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2774292</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1994 Jan;169(1):68-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8277200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876</Citation><ArticleIdList><ArticleId IdType="pubmed">20166072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Dec 15;151(12):840-53</Citation><ArticleIdList><ArticleId IdType="pubmed">20008760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Boggild, Andrea K" sort="Boggild, Andrea K" uniqKey="Boggild A" first="Andrea K" last="Boggild">Andrea K. Boggild</name><name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name></noCountry><country name="Canada"><noRegion><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000515 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000515 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21668681
|texte= Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21668681" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |